Alotendin 30 tablets

Alotendin Composition:
active substances: amlodipine, bisoprolol;

1 tablet of Alotendin 5 mg / 5 mg contains 5 mg of bisoprolol fumarate and 5 mg of amlodipine, corresponding to 6.95 mg of amlodipine besylate;

1 tablet of Alotendine 10 mg / 5 mg contains 10 mg of bisoprolol fumarate and 5 mg of amlodipine, corresponding to 6.95 mg of amlodipine besylate;

1 tablet of Alotendin 5 mg / 10 mg contains 5 mg of bisoprolol fumarate and 10 mg of amlodipine, corresponding to 13.9 mg of amlodipine besylate;

Excipients: microcrystalline cellulose, sodium starch glycolate (type A), colloidal anhydrous silica, magnesium stearate.

Indications:

Arterial hypertension as monotherapy or in combination with other antihypertensive agents.

Chronic stable angina pectoris as monotherapy or in combination with other antianginal drugs.
As replacement therapy in patients whose blood pressure and / or chronic stable angina adequately supervised while using amlodipine and bisoprolol in the same dosages.

Contraindications

For amlodipine, unstable angina, aortic stenosis pronounced.

For bisoprolol, acute heart failure, cardiogenic shock, AV-block II-III degree, syndrome weakness sinus node sinoatrial block, bradycardia (heart rate less than 60 per minute) before treatment hypotension (systolic blood pressure <100 mm Hg. c.), asthma, chronic obstructive pulmonary disease, expressed by human peripheral blood, Raynaud’s syndrome, pheochromocytoma untreated, metabolic acidosis.

For tablets amlodipine / bisoprolol: hypersensitivity to amlodipine, dihydropyridine derivatives, bisoprolol and / or any excipient, lactation, children’s age (18).

Dosage & Administration

The recommended dose is one tablet dosage appropriate, desirable to take medication in the morning regardless of the meal, not liquid.

The maximum daily dose – 1 tablet Alotendynu 10 mg / 10 mg per day.

The range of dosage ratio allows flexibility to choose components based on clinical needs.

Treatment should not stop abruptly as this can cause temporary worsening of clinical status. This is especially true for patients with coronary heart disease. It is recommended to gradually reduce the dose.

Contact us for more details.